Sainor Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.31 Cr
as on 16-11-2024
- Company Age 20 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 151.39 Cr
as on 16-11-2024
- Satisfied Charges ₹ 68.53 Cr
as on 16-11-2024
- Revenue 122.65%
(FY 2023)
- Profit 157.34%
(FY 2023)
- Ebitda 134.30%
(FY 2023)
- Net Worth 88.46%
(FY 2023)
- Total Assets 71.63%
(FY 2023)
About Sainor Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 3.31 Cr.
The company currently has active open charges totaling ₹151.39 Cr. The company has closed loans amounting to ₹68.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pullaiah Sundara, Nagaudaya Uddagiri, Srinivas Nadiminti, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC044758
- Company No.
044758
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sainor Laboratories Private Limited offer?
Sainor Laboratories Private Limited offers a wide range of products and services, including API Intermediate, Bromine Compound, Allyl Bromide, Nano Powder, Magnesium Powders, Inorganic Salts, Magnesium Chloride, Chemical Reagents & Catalysts, Organic Compounds, Zinc Bromide.
Who are the key members and board of directors at Sainor Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjaneya Chandana  | Managing Director | 05-Jun-2013 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pullaiah Sundara | Whole-Time Director | 06-Jun-2013 | Current |
| Nagaudaya Uddagiri | Whole-Time Director | 02-Dec-2004 | Current |
| Srinivas Nadiminti | Whole-Time Director | 01-Feb-2016 | Current |
| Kadiri Shilpa | Whole-Time Director | 01-Feb-2016 | Current |
| Anajali Sundara | Whole-Time Director | 02-Dec-2004 | Current |
| Uddagiri Rao | Director | 06-Jun-2013 | Current |
Financial Performance and Corporate Structure Insights of Sainor Laboratories.
Sainor Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 122.65% increase. The company also saw a substantial improvement in profitability, with a 157.34% increase in profit. The company's net worth Soared by an impressive increase of 88.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sainor Laboratories?
In 2023, Sainor Laboratories had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Organor Chemicals LlpActive 1 year 11 monthsPullaiah Sundara, Anjaneya Chandana and 1 more are mutual person
Sainor Pharma Private LimitedActive 3 years 7 daysPullaiah Sundara, Anjaneya Chandana and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Nov 2023 | ₹2.77 M | Open |
Others Creation Date: 22 Dec 2022 | ₹4.50 Cr | Open |
Others Creation Date: 03 Dec 2020 | ₹125.46 Cr | Open |
How Many Employees Work at Sainor Laboratories?
Sainor Laboratories has a workforce of 136 employees as of Jul 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sainor Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sainor Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
